Inovio's HCV Vaccine Trial Delivers Good Results
Inovio Biomedical’s hepatitis C vaccine progresses
Philadelphia Business Journal – by John George Staff Writer
Monday, November 30, 2009
Inovio Biomedical Corp. said Monday its drug-development partner Tripep completed a phase-I clinical study of its hepatitis C DNA vaccine.
Tripep of Sweden tested its vaccine, called ChronVac-C and delivered using Inovio’s electroporation technology, in 12 patients with positive results.
Continue reading the entire article: